Announcement on the Public Recruitment and Selection of Restructuring Intent Investors by the Temporary Administrator
Yan'an Bikan Pharmaceutical Co., Ltd. and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On May 12, 2023, the Intermediate People's Court of Yan'an issued Decision No. (2023) Shaan 06 Bankruptcy Application 3, accepting the bankruptcy pre-restructuring case of Yan'an Bikan Pharmaceutical Co., Ltd. (hereinafter referred to as "Yan'an Bikan," "the listed company," or "the company"). On May 15, 2023, the court issued Decision No. (2023) Shaan 06 Bankruptcy Application 3-1, designating Shaanxi Moda Law Firm as the temporary administrator for the bankruptcy pre-restructuring case of Yan'an Bikan (hereinafter referred to as "the temporary administrator").
To smoothly advance the pre-restructuring work of Yan'an Bikan and improve restructuring efficiency, while safeguarding the legitimate rights and interests of all creditors and maximizing the operational value of the company, the temporary administrator is now publicly recruiting and selecting restructuring intent investors in accordance with the Enterprise Bankruptcy Law of the People's Republic of China and relevant legal provisions. The details of the recruitment and selection are as follows:
Company Overview
- Company Name: Yan'an Bikan Pharmaceutical Co., Ltd.
- Company Address: E District, Innovation and Entrepreneurship Town, Baota District, Yan'an City, Shaanxi Province
- Company Registration Authority: Yan'an Market Supervision Administration
- Company Registered Capital: RMB 1,532,283,909
- Stock Exchange and Securities Code: The company's stock is listed and traded on the Shenzhen Stock Exchange, with the securities code 002411. Due to the implementation of delisting risk warning, the stock has been referred to as "*ST Bikan" since July 1, 2022.
- Business Scope: Procurement of Chinese medicinal materials; production and sales of pharmaceuticals; production and sales of 7-amino-3-deacetoxycephalosporanic acid (7-ADCA), 5,5-dimethylhydantoin and its derivatives, sodium trichloropyridinol, lithium hexafluorophosphate, lithium battery separators, high-strength high-modulus polyethylene fibers, non-woven fabrics and products, hydrochloric acid, hydrofluoric acid (anhydrous), hydrogen fluoride, phenylacetic acid, ammonium chloride, ammonium sulfate, pyridine sulfate salt, and plastic products (the production and sales of the above products must comply with environmental protection approval opinions); manufacturing and installation of machinery and equipment (excluding pressure vessels); export of self-produced products and technology, and import of machinery, spare parts, raw and auxiliary materials, and technology required by the enterprise (excluding goods and technologies restricted or prohibited by the state).
Purpose of Recruitment and Selection
The purpose of this recruitment for restructuring intent investors is to coordinate and promote the completion of the company's pre-restructuring work, striving to maximize the interests of Yan'an Bikan's shareholders, creditors, and investors. Restructuring intent investors will provide financial support, allowing shareholders and creditors to mutually accommodate each other, achieving a comprehensive optimization of the debtor's asset structure, governance structure, and equity structure, effectively integrating industrial resources, and creating a high-quality listed company with a reasonable equity structure, sound governance structure, excellent asset quality, and sustainable operational and profitability capabilities.